Tumor progression and metastatic dissemination in ovarian cancer after dose-dense or conventional paclitaxel and cisplatin plus bevacizumab-Reference-Cited by-同舟云学术

Tumor progression and metastatic dissemination in ovarian cancer after dose-dense or conventional paclitaxel and cisplatin plus bevacizumab

Published:2018-08-07 Issue:9 Volume:143 Page:2187-2199
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Bizzaro Francesca¹,Falcetta Francesca²,D’Agostini Elisa¹,Decio Alessandra¹,Minoli Lucia¹³⁴,Erba Eugenio²,Alessandro Peccatori Fedro⁵,Scanziani Eugenio³,Colombo Nicoletta⁵,Zucchetti Massimo²,Bani Maria Rosa¹,Ubezio Paolo²,Giavazzi Raffaella¹^ORCID

Affiliation:

1. Laboratory of Biology and Treatment of Metastasis, Department of Oncology; IRCCS-Istituto di Ricerche Farmacologiche Mario Negri; Milan Italy

2. Laboratory of Anticancer Pharmacology, Department of Oncology; IRCCS-Istituto di Ricerche Farmacologiche Mario Negri; Milan Italy

3. Department of Veterinary Medicine; University of Milan; Milan Italy

4. Mouse and Animal Pathology Lab (MAPLab); Fondazione Filarete; Milan Italy

5. University of Milano-Bicocca and Gynecologic Oncology Division, European Institute of Oncology; Milan Italy

Funder

Italian Association for Cancer Research

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ijc.31596/fullpdf

Reference36 articles.

1. 2010 Gynecologic Cancer InterGroup (GCIG) consensus statement on clinical trials in ovarian cancer: report from the Fourth Ovarian Cancer Consensus Conference;Stuart;Int J Gynecol Cancer,2011

2. Bevacizumab in ovarian cancer: a critical review of phase III studies;Rossi;Oncotarget,2017

3. Relationship of mitotic arrest and apoptosis to antitumor effect of paclitaxel;Milross;J Natl Cancer Inst,1996

4. The microtubule-affecting drug paclitaxel has antiangiogenic activity;Belotti;Clin Cancer Res,1996

5. The anti-angiogenic basis of metronomic chemotherapy;Kerbel;Nat Rev Cancer,2004

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Low-dose Cisplatin Induces Tumor GrowthviaMobilization of Proangiogenic Bone Marrow-derived Cells in Mouse Models;Anticancer Research;2023-11-29

2. The DNA-PK Inhibitor AZD7648 Sensitizes Patient-Derived Ovarian Cancer Xenografts to Pegylated Liposomal Doxorubicin and Olaparib Preventing Abdominal Metastases;Molecular Cancer Therapeutics;2022-02-11

3. Anti‐tumoural activity of the G‐quadruplex ligand pyridostatin against BRCA1/2‐deficient tumours;EMBO Molecular Medicine;2022-02-02

4. HEYL Regulates Neoangiogenesis Through Overexpression in Both Breast Tumor Epithelium and Endothelium;Frontiers in Oncology;2021-01-15

5. Anti-vascular nano agents: a promising approach for cancer treatment;Journal of Materials Chemistry B;2020